Use of Immunomatrix Methods to Improve Protein-Protein Interaction Detection

Journal of Biomedicine and Biotechnology

Volumn 2003, Issue 5, 2003, Pages 291-298

  Qoronfleh, M Walid ^a   Ren, Ling ^a   Emery, Daryl ^a   Perr, Maria ^a   Kaboord, Barbara ^a  

^a Bioresearch Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMOBILIZED ANTIBODY; PROTEIN;

ANTIGEN RECOGNITION; ARTICLE; IMMUNOCHEMISTRY; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; PROTEIN CROSS LINKING; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION;

EID: 0942287183     PISSN: 11107243     EISSN: None     Source Type: Journal    
DOI: 10.1155/S1110724303209256     Document Type: Article

References (29)

1. Williams NE. Immunoprecipitation procedures. Methods Cell Biol. 2000;62:449-453.
2. Harlow Ed, Lane D. Using Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1999.
3. Otto JJ, Lee SW. Immunoprecipitation methods. Methods Cell Biol. 1993;37:119-127.
4. Ransone LJ. Detection of protein-protein interactions by coimmunoprecipitation and dimerization. Methods Enzymol. 1995;254:491-497.
5. Shi Y, Ullrich SJ, Zhang J, et al. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem. 2000;275(25):19167-19176.
6. Honda R, Tanaka H, Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 1997;420(1):25-27.
7. Yamauchi J, Kaziro Y, Itoh H. C-terminal mutation of G protein beta subunit affects differentially extracellular signal-regulated kinase and c-Jun N-terminal kinase pathways in human embryonal kidney 293 cells. J Biol Chem. 1997;272(12):7602-7607.
8. Tanimura S, Ohtsuka S, Mitsui K, Shirouzu K, Yoshimura A, Ohtsubo M. MDM2 interacts with MDMX through their RING finger domains. FEBS Lett. 1999;447(1):5-9.
9. Wong C, Naumovski L. Method to screen for relevant yeast two-hybrid-derived clones by coimmunoprecipitation and colocalization of epitope-tagged fragments-application to Bcl-xL. Anal Biochem. 1997;252(1):33-39.
10. Estojak J, Brent R, Golemis EA. Correlation of two-hybrid affinity data with in vitro measurements. Mol Cell Biol. 1995;15(10):5820-5829.
11. Wiese C, Galande S. Elimination of reducing agent facilitates quantitative detection of p53 antigen. Biotechniques. 2001;30(5):960-963.
12. Berryman M, Bretscher A. Immunoblot detection of antigens in immunoprecipitates. Biotechniques. 2001;31(4):744-746.
13. Scopes PK, Smith JA. Analysis of protein. In: Ausubal FM, Brent R, Kingston RE, et al. Eds. Current Protocols in Molecular Biology. New York, NY: John Wiley & Sons; 1994:10.6.3.
14. Hermanson GT, Mallia AK, Smith PK. Immobilized Affinity Ligand Techniques. San Diego, Calif: Academic Press; 1992.
15. Hermanson GT. Bioconjugate Techniques. San Diego, Calif: Academic Press; 1996.
16. Cox GW, Mathieson BJ, Giardina SL, Varesio L. Characterization of IL-2 receptor expression and function on murine macrophages. J Immunol. 1990;145(6):1719-1726.
17. Rechsteiner M, Hoffman L, Dubiel W, The multicatalytic and 26S proteases. J Biol Chem. 1993;268(9):6065-6068.
18. Eytan E, Armon T, Heller H, Beck S, Hershko A. Ubiquitin C-terminal hydrolase activity associated with the 26S proteasome complex. J Biol Chem. 1993;268(7):4668-4674.
19. Groll M, Ditzel L, Lowe J, et al. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature. 1997;386(6624):463-471.
20. Tanahashi N, Tsurumi C, Tamura T, Tanaka K. Molecular structure of 20S and 26S proteasomes. Enzyme Protein. 1993;47(4-6):241-251.
21. Tanaka K, Tsurumi C. The 26S proteasome: subunits and functions. Mol Biol Rep. 1997;24(1-2):3-11.
22. Chu-Ping M, Vu JH, Proske RJ, Slaughter CA, DeMartino GN. Identification, purification, and characterization of a high molecular weight, ATP-dependent activator (PA700) of the 20 S proteasome. J Biol Chem. 1994;269(5):3539-3547.
23. DaFonseca CJ, Shu F, Zhang JJ. Identification of two residues in MCM5 critical for the assembly of MCM complexes and Stat1-mediated transcription activation in response to IFN-gamma. Proc Natl Acad Sci USA. 2001;98(6):3034-3039.
24. Littlewood TD, Amati B, Land H, Evan GI. Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene. 1992;7(9):1783-1792.
25. Brymora A, Cousin MA, Roufogalis BD, Robinson PJ. Enhanced protein recovery and reproducibility from pull-down assays and immunoprecipitations using spin columns. Anal Biochem. 2001;295(1):119-122.
26. Juven-Gershon T, Oren M. Mdm2: the ups and downs. Mol Med. 1999;5(2):71-83.
27. Freeman DA, Wu L, Levine AJ. Functions of the MDM2 oncoprotein. Cell Mol Life Sci. 1999;55(1): 96-107.
28. Haines DS. The mdm2 proto-oncogene. Leuk Lymphoma. 1997;26(3-4):227-238.
29. Haines DS, Landers JE, Engle LJ, George DL. Physical and functional interaction between wild-type 53 and mdm2 proteins. Mol Cell Biol. 1994;14(2):1171-1178.